Neuronetics, Inc. - Common Stock, $0.01 par value (STIM)

CUSIP: 64131A105

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
69,254,377
Total 13F shares
41,645,979
Share change
-567,637
Total reported value
$60,363,694
Put/Call ratio
64%
Price per share
$1.45
Number of holders
99
Value change
-$718,050
Number of buys
48
Number of sells
44

Security key

64131A105

Report period

Q1 2026

Institutions

99

Top holders

10

Top shareholders of STIM - Neuronetics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Madryn Asset Management, LP
13D/G 3/4/5 13F
10%+ Owner · Company
30%
20,737,061
$32,764,556 $0 02 Mar 2026
Jorey Chernett
13D/G
Chernett Jorey
9.9%
6,827,031
$0 30 Jan 2026
MADRYN HEALTH ADVISORS GP II, LLC
3/4/5
10%+ Owner
25%
17,044,940
$21,987,972 10 Jul 2025
MADRYN HEALTH ADVISORS II, LP
3/4/5
10%+ Owner
25%
17,044,940
$21,987,972 10 Jul 2025
MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP
3/4/5
10%+ Owner
25%
17,044,940
$21,987,972 10 Jul 2025
Madryn Health Partners II, LP
3/4/5
10%+ Owner
25%
17,044,940
$21,987,972 10 Jul 2025
Sasha Cucuz
3/4/5
Director
2.9%
2,030,924
$5,544,421 20 Oct 2025
Keith J. Sullivan
3/4/5
Former Officer & Director
2.3%
1,590,924
$2,131,838 -$192,798 19 Mar 2026
Daniel L. Reuvers
3/4/5
President and CEO
2.2%
1,500,000
$1,905,000 23 Mar 2026
William Andrew Macan
3/4/5
EVP, CLO and CS
1.3%
897,270
$1,202,341 -$55,589 19 Mar 2026
Steven Pfanstiel
3/4/5
Former EVP, CFO and Treasurer
1.2%
836,643
$1,121,101 -$11,482 19 Mar 2026
Robert Cascella
3/4/5
Director
0.85%
588,767
$1,607,333 20 Oct 2025
Glenn P. Muir
3/4/5
Director
0.54%
371,816
$1,015,057 20 Oct 2025
Sheryl L. Conley
3/4/5
Director
0.32%
221,716
$605,284 20 Oct 2025
Megan Rosengarten
3/4/5
Director
0.2%
140,890
$597,373 22 May 2025
Avinash Amin
3/4/5
Director
0.06%
42,500
$180,200 22 May 2025
UBS Group AG
13F
Company
3.8%
2,607,047
$3,597,725 31 Dec 2025
13F
VANGUARD GROUP INC
13F
Company
3.7%
2,582,382
$3,563,687 31 Dec 2025
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
3.7%
2,552,404
$3,522,318 31 Dec 2025
13F
BlackRock, Inc.
13F
Company
3.4%
2,353,751
$3,248,177 31 Dec 2025
13F
Lane Generational LLC
13F
Company
2.5%
1,705,197
$2,353,172 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
1.5%
1,017,862
$1,404,650 31 Dec 2025
13F
MASTERS CAPITAL MANAGEMENT LLC
13F
Company
1.4%
1,000,000
$1,380,000 31 Dec 2025
13F
FourWorld Capital Management LLC
13F
Company
1.3%
931,250
$1,285,125 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
891,733
$1,230,805 31 Dec 2025
13F
Ikarian Capital, LLC
13F
Company
1%
701,182
$967,631 31 Dec 2025
13F
WEXFORD CAPITAL LP
13F
Company
0.93%
644,951
$890,030 31 Dec 2025
13F
STATE STREET CORP
13F
Company
0.84%
584,167
$806,150 31 Dec 2025
13F
HighTower Advisors, LLC
13F
Company
0.81%
564,306
$778,742 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.69%
474,900
$655,362 31 Dec 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.48%
331,954
$458,096 31 Dec 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.46%
321,561
$443,754 31 Dec 2025
13F
XTX Topco Ltd
13F
Company
0.45%
314,194
$433,588 31 Dec 2025
13F
MARSHALL WACE, LLP
13F
Company
0.41%
286,045
$394,743 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.4%
278,400
$384,192 31 Dec 2025
13F
AdvisorShares Investments LLC
13F
Company
0.39%
270,916
$373,864 31 Dec 2025
13F
JBF Capital, Inc.
13F
Company
0.34%
233,166
$321,769 31 Dec 2025
13F
Massar Capital Management, LP
13F
Company
0.32%
221,000
$304,980 31 Dec 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.29%
198,745
$274,268 31 Dec 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.25%
175,000
$241,500 31 Dec 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.24%
169,000
$233,220 31 Dec 2025
13F
Dauntless Investment Group, LLC
13F
Company
0.23%
160,927
$222,079 31 Dec 2025
13F
Aristides Capital LLC
13F
Company
0.2%
136,400
$188,232 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
0.17%
116,431
$160,675 31 Dec 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.16%
108,208
$149,327 31 Dec 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
95,205
$131,383 31 Dec 2025
13F
Caption Management, LLC
13F
Company
0.13%
92,501
$127,651 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.13%
92,421
$127,541 31 Dec 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.13%
91,129
$125,758 31 Dec 2025
13F
GAMCO INVESTORS, INC. ET AL
13F
Company
0.11%
79,200
$109,296 31 Dec 2025
13F

Institutional Holders of Neuronetics, Inc. - Common Stock, $0.01 par value (STIM) as of Q1 2026

As of 31 Mar 2026, Neuronetics, Inc. - Common Stock, $0.01 par value (STIM) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,645,979 shares. The largest 10 holders included Madryn Asset Management, LP, UBS Group AG, Balyasny Asset Management L.P., BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, Lane Generational LLC, FourWorld Capital Management LLC, MASTERS CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 99 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
95
Q1 2026 holders
99
Holder diff
4
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .